Featured Research

from universities, journals, and other organizations

IUD Is Most Popular Long-acting Contraceptive Amongst Europeans

Date:
November 11, 2009
Source:
FECYT - Spanish Foundation for Science and Technology
Summary:
A European study has defined the profile for the usage of long-acting contraceptive methods. The work shows, amongst other things, that 10 percent of women use these methods, the majority over 30 years old.

New research finds that the IUD is the most popular long-acting contraceptive amongst Europeans.
Credit: SINC

A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynaecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old.

"Long-acting contraceptives (the IUD, contraceptive injection or contraceptive implant) are still not widely used," Sergio Haimovich, researcher at the Hospital del Mar in Barcelona and author of the study published in the European Journal Of Contraception And Reproductive Health Care, explains.

After the male condom, the pill is the most popular contraceptive method amongst European women, while intrauterine contraception (copper IUD or hormone-releasing IUS) is most popular as a long-term solution. Of the more than 11,000 women surveyed in 14 European countries, longer-lasting methods were used by 1,088 women, 10% of the sample.

The Spanish research, part of a broader study on the general contraceptive profile of European women, evaluates the use of long-acting reversible contraceptives. According to Haimovich, "those using them are women over the age of 30 who do not want more children and who are looking for a long-term solution." Younger girls use different methods, according to the expert.

The reasons why certain contraceptive methods are chosen, and how, are unknown. But why is there a scientific interest in the user profile? "The answers to these questions can help us to formulate contraceptive advice that is better adapted to the needs of the users," explains Haimovich.

The condom triumphs in Spain

The data consider the specific needs of each country. Spain is one of the European countries where the condom is used most, by all ages. However, according to the study hormonal methods, such as the pill or the ring, are increasingly being used.

The results of this research, awarded best work at the National Congress of Gynaecology on 25 September this year, "help to explain what users want and enable a more appropriate contraceptive check to be created," affirms Haimovich. "That is why we must always adapt our discourse to the demands of the users, and work such as this makes us aware of these requirements," the scientist points out.


Story Source:

The above story is based on materials provided by FECYT - Spanish Foundation for Science and Technology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sergio Haimovich. Profile of long-acting reversible contraception users in Europe. European Journal Of Contraception And Reproductive Health Care, 2009

Cite This Page:

FECYT - Spanish Foundation for Science and Technology. "IUD Is Most Popular Long-acting Contraceptive Amongst Europeans." ScienceDaily. ScienceDaily, 11 November 2009. <www.sciencedaily.com/releases/2009/10/091028134635.htm>.
FECYT - Spanish Foundation for Science and Technology. (2009, November 11). IUD Is Most Popular Long-acting Contraceptive Amongst Europeans. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/10/091028134635.htm
FECYT - Spanish Foundation for Science and Technology. "IUD Is Most Popular Long-acting Contraceptive Amongst Europeans." ScienceDaily. www.sciencedaily.com/releases/2009/10/091028134635.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins